JPM vs MKTW
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
MKTW presents a deceptive value trap characterized by a stable Piotroski F-Score of 4/9 but critical underlying financial instability. While the current P/E is low, the explosion in Forward P/E (82.45) and negative Price-to-Book ratio (-3.45) indicate severe equity erosion and expected earnings collapse. Liquidity is a primary concern with a Current Ratio of 0.56, and the long-term 5-year price trend (-89%) reflects systemic value destruction. Despite a healthy dividend yield, the combination of declining revenue, bearish insider selling by the CFO, and negative equity makes the risk profile unacceptable.
Compare Another Pair
Related Comparisons
JPM vs MKTW: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and MarketWise, Inc. (MKTW) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.